|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||116.75 - 116.75|
|52 Week Range||102.13 - 131.37|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||25.41|
|Forward Dividend & Yield||2.34 (1.98%)|
|Ex-Dividend Date||Oct. 22, 2021|
|1y Target Est||N/A|
UNVR vs. AKZOY: Which Stock Is the Better Value Option?
"We expect the raw material situation in 2022 to be less hectic," Chief Executive Thierry Vanlancker said in a call with analysts, adding that inflation will still be at the forefront in the first half of the year. "Hopefully we will get a little bit more breathing room, but we're not betting on that, and our whole pricing plan and our whole market plan is based on the current situation," Vanlancker said. The rebound in economic activity as coronavirus restrictions are eased has exposed shortages across supply chains, with companies scrambling to find workers, ships and even fuel to power factories, threatening the recovery and keeping central bankers on high alert over inflation and its impact on rate decisions.
Nouryon BV, the former chemicals arm of AkzoNobel, said on Friday it had filed an application with the U.S. Securities and Exchange Commission (SEC) to seek an initial public offering (IPO) of shares. Akzo sold Nouryon to The Carlyle Group in 2018 in a deal then worth 10.1 billion euros ($12 billion). Nouryon had adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of $970 million in 2020 on sales of $4.2 billion, a company fact sheet published on its website said.